Search Results - "Grotzer, M"

Refine Results
  1. 1

    Quassinoids: From traditional drugs to new cancer therapeutics by Fiaschetti, G, Grotzer, M A, Shalaby, T, Castelletti, D, Arcaro, A

    Published in Current medicinal chemistry (2011)
    “…Quassinoids are a group of compounds extracted from plants of the Simaroubaceae family, which have been used for many years in folk medicine. These molecules…”
    Get more information
    Journal Article
  2. 2
  3. 3
  4. 4

    Epigenetic silencing of miRNA-9 is associated with HES1 oncogenic activity and poor prognosis of medulloblastoma by Fiaschetti, G, Abela, L, Nonoguchi, N, Dubuc, A M, Remke, M, Boro, A, Grunder, E, Siler, U, Ohgaki, H, Taylor, M D, Baumgartner, M, Shalaby, T, Grotzer, M A

    Published in British journal of cancer (04-02-2014)
    “…Background: microRNA-9 is a key regulator of neuronal development aberrantly expressed in brain malignancies, including medulloblastoma. The mechanisms by…”
    Get full text
    Journal Article
  5. 5

    Microbeam radiation therapy: Clinical perspectives by Grotzer, M.A, Schültke, E, Bräuer-Krisch, E, Laissue, J.A

    Published in Physica medica (01-09-2015)
    “…Abstract Microbeam radiation therapy (MRT), a novel form of spatially fractionated radiotherapy (RT), uses arrays of synchrotron-generated X-ray microbeams…”
    Get full text
    Journal Article
  6. 6

    Cerebellar stem cells act as medulloblastoma-initiating cells in a mouse model and a neural stem cell signature characterizes a subset of human medulloblastomas by Sutter, R, Shakhova, O, Bhagat, H, Behesti, H, Sutter, C, Penkar, S, Santuccione, A, Bernays, R, Heppner, F L, Schüller, U, Grotzer, M, Moch, H, Schraml, P, Marino, S

    Published in Oncogene (25-03-2010)
    “…Cells with stem cell properties have been isolated from various areas of the postnatal mammalian brain, most recently from the postnatal mouse cerebellum. We…”
    Get full text
    Journal Article
  7. 7

    Mismatch repair deficiency: a temozolomide resistance factor in medulloblastoma cell lines that is uncommon in primary medulloblastoma tumours by von Bueren, A O, Bacolod, M D, Hagel, C, Heinimann, K, Fedier, A, Kordes, U, Pietsch, T, Koster, J, Grotzer, M A, Friedman, H S, Marra, G, Kool, M, Rutkowski, S

    Published in British journal of cancer (09-10-2012)
    “…Background: Tumours are responsive to temozolomide (TMZ) if they are deficient in O 6 -methylguanine-DNA methyltransferase (MGMT), and mismatch repair (MMR)…”
    Get full text
    Journal Article
  8. 8

    Hearing loss and quality of life in survivors of paediatric CNS tumours and other cancers by Weiss, Annette, Sommer, Grit, Schindera, Christina, Wengenroth, Laura, Karow, Axel, Diezi, Manuel, Michel, Gisela, Kuehni, Claudia E.

    Published in Quality of life research (01-02-2019)
    “…Purpose Hearing loss, a complication of cancer treatment, may reduce health-related quality of life (HRQoL), especially in childhood cancer survivors of…”
    Get full text
    Journal Article
  9. 9

    Prospects for microbeam radiation therapy of brain tumours in children to reduce neurological sequelae by Laissue, JA, Blattmann, H, Wagner, H P, Grotzer, M A, Slatkin, D N

    Published in Developmental medicine and child neurology (01-08-2007)
    “…Microbeam radiation therapy (MRT), a form of experimental radiosurgery of tumours using multiple parallel, planar, micrometres‐wide, synchrotron‐generated…”
    Get full text
    Journal Article
  10. 10

    Telomerase inhibition, telomere shortening, cell growth suppression and induction of apoptosis by telomestatin in childhood neuroblastoma cells by Binz, N., Shalaby, T., Rivera, P., Shin-ya, K., Grotzer, M.A.

    Published in European journal of cancer (1990) (01-12-2005)
    “…Neuroblastoma is a tumour derived from primitive cells of the sympathetic nervous system and is the most common extracranial solid tumour in childhood…”
    Get full text
    Journal Article
  11. 11

    Outcome of medulloblastoma in children: long-term complications and quality of life by Ribi, K, Relly, C, Landolt, M A, Alber, F D, Boltshauser, E, Grotzer, M A

    Published in Neuropediatrics (01-12-2005)
    “…To study the outcomes in long-term survivors of paediatric medulloblastoma (MB), we followed 51 consecutive children who were treated between 1980 and 2000 in…”
    Get more information
    Journal Article
  12. 12

    Bone morphogenetic protein-7 is a MYC target with prosurvival functions in childhood medulloblastoma by Fiaschetti, G, Castelletti, D, Zoller, S, Schramm, A, Schroeder, C, Nagaishi, M, Stearns, D, Mittelbronn, M, Eggert, A, Westermann, F, Ohgaki, H, Shalaby, T, Pruschy, M, Arcaro, A, Grotzer, M A

    Published in Oncogene (23-06-2011)
    “…Medulloblastoma (MB) is the most common malignant brain tumor in children. It is known that overexpression and/or amplification of the MYC oncogene is…”
    Get full text
    Journal Article
  13. 13

    Spatial clustering of childhood cancers in Switzerland: a nationwide study by Konstantinoudis, Garyfallos, Kreis, Christian, Ammann, Roland A., Niggli, Felix, Kuehni, Claudia E., Spycher, Ben D.

    Published in Cancer causes & control (01-03-2018)
    “…Purpose Childhood cancers are rare and little is known about their etiology. Potential risk factors include environmental exposures that might implicate…”
    Get full text
    Journal Article
  14. 14
  15. 15

    Concentration, working speed and memory: Cognitive problems in young childhood cancer survivors and their siblings by Wengenroth, L., Rueegg, C. S., Michel, G., Gianinazzi, M. E., Essig, S., von der Weid, N. X., Grotzer, M., Kuehni, Claudia E.

    Published in Pediatric blood & cancer (01-05-2015)
    “…Background Cognitive problems can have a negative effect on a person's education, but little is known about cognitive problems in young childhood cancer…”
    Get full text
    Journal Article
  16. 16
  17. 17

    TrkC Expression Predicts Good Clinical Outcome in Primitive Neuroectodermal Brain Tumors by GROTZER, M. A, JANSS, A. J, TROJANOWSKI, J. Q, FUNG, K.-M, BIEGEL, J. A, SUTTON, L. N, RORKE, L. B, ZHAO, H, CNAAN, A, PHILLIPS, P. C, LEE, V. M.-Y

    Published in Journal of clinical oncology (01-03-2000)
    “…To identify biologic prognostic factors in childhood primitive neuroectodermal tumors (PNET), including medulloblastoma, that accurately define patient groups…”
    Get full text
    Journal Article
  18. 18

    Antisense treatment of IGF-IR induces apoptosis and enhances chemosensitivity in central nervous system atypical teratoid/rhabdoid tumours cells by D’cunja, J, Shalaby, T, Rivera, P, von Büren, A, Patti, R, Heppner, F.L, Arcaro, A, Rorke-Adams, L.B, Phillips, P.C, Grotzer, M.A

    Published in European journal of cancer (1990) (01-07-2007)
    “…Abstract Central nervous system (CNS) atypical teratoid/rhabdoid tumours (AT/RT) are among the paediatric malignant tumours with the worst prognosis and fatal…”
    Get full text
    Journal Article
  19. 19

    Outcome in children with brain tumours diagnosed in the first year of life: long-term complications and quality of life by Gerber, N U, Zehnder, D, Zuzak, T J, Poretti, A, Boltshauser, E, Grotzer, M A

    Published in Archives of disease in childhood (01-07-2008)
    “…Objective:To study the outcome in children with brain tumours diagnosed in the first year of life, we followed up 27 consecutive children who were diagnosed…”
    Get full text
    Journal Article
  20. 20

    Port-A-Cath infections in children with cancer by Hengartner, H., Berger, C., Nadal, D., Niggli, F.K., Grotzer, M.A.

    Published in European journal of cancer (1990) (01-11-2004)
    “…Implanted subcutaneous (s.c.) central venous port accesses including Port-A-Cath (PAC) facilitate the administration of chemotherapy or blood products and are…”
    Get full text
    Journal Article